Loading organizations...
§ Private Profile · Caesarea, Hefa, Israel
Develops RevDx, a portable, automated hematology lab for complete blood count results in field settings and underserved areas.
Based in Caesarea, Israel, EfA Technologies develops RevDx, a portable and fully automated hematology laboratory designed to deliver complete blood count diagnostics in field settings without requiring electricity, internet connectivity, or specialized medical expertise. The medical device supports telemedicine applications and focuses primarily on distinguishing between viral and bacterial infections in patients presenting with fever across emerging markets and underserved communities. Operating as a Series A stage company, the enterprise currently maintains a workforce of 12 employees and has raised a total of $7.4 million in funding to date to support its planned expansion into Europe and the United States. The diagnostic technology developer is backed by a syndicate of strategic and institutional investors, including Maccabi HMO, Merchavia Group, eHealth Ventures, and the Israel Innovation Authority. EfA Technologies was founded in 2016 by Yoel Ezra.
EfA Technologies has raised $7.4M across 2 funding rounds.
EfA Technologies has raised $7.4M in total across 2 funding rounds.
EfA Technologies has raised $7.4M across 2 funding rounds. Most recently, it raised $6.5M Other Equity in April 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 11, 2024 | $6.5M Venture Round | ARC Impact, EHealth Ventures, Israeli Innovation Authority, Venturing Tech | — | Announced |
| Dec 12, 2018 | $900K Seed | EHealth Ventures | — | Announced |
EfA Technologies has raised $7.4M in total across 2 funding rounds.
EfA Technologies's investors include Arc Impact, eHealth Ventures, Israeli Innovation Authority, Venturing Tech.